Haleon Plc - ADR (HLN)
NYSE
Closed
Aug 24, 2026
Day's Range
9.9752 wk Range
8.65Overview - HLN - Haleon Plc - ADR
Key Statistics
Valuation
Enterprise Value
70.89B
P/E (Trailing)
‪20.40‬
P/E (Forward)
‪16.04‬
PEG Ratio
‪16.04‬
Price / Sales (TTM)
‪3.94‬
Price / Book
‪1.98‬
EV / EBITDA
‪18.22‬
Profitability
Gross Margin
‪55.38%‬
Profit Margin
‪14.55%‬
Operating Margin
‪23.93%‬
Return on Assets
‪5.08%‬
Return on Equity
‪10.09%‬
Ownership
Shares Outstanding
8.90B
Float
4.42B
Short % of Shares Outstanding
‪0.41%‬
Held by Insiders
‪0.01%‬
Held by Institutions
‪13.54%‬
Price stats
Beta
‪0.24‬
50-Day Avg
‪9.67‬
200-Day Avg
‪9.82‬
Dividends
Payout Ratio
‪39.53%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - HLN - Haleon Plc - ADR
Related Symbols
Other instruments in the same class.
Profile Summary - HLN - Haleon Plc - ADR
About
Haleon Plc - ADR represents an American Depositary Receipt for Haleon Plc, a company known for its focus on consumer healthcare products. ADRs are traded on U.S. stock exchanges and allow American investors to invest in non-U.S. companies without dealing with foreign transactions. Haleon Plc specializes in providing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
